<DOC>
	<DOCNO>NCT00200473</DOCNO>
	<brief_summary>A study determine safety , efficacy superiority nebivolol placebo treatment elevate blood pressure patient mild moderate hypertension .</brief_summary>
	<brief_title>A Study Safety Efficacy Nebivolol Hypertensive Patients</brief_title>
	<detailed_description>This study multi-center , multi-national , randomize , double-blind , parallel group , placebo-controlled study nebivolol range dose patient mild moderate hypertension . The study consist 2 phase : screening/washout/single-blind placebo run-in 2 ) randomization/double-blind treatment . Patients 7 schedule clinic visit study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<criteria>An average sit diastolic blood pressure great equal 95 mmHg less equal 109 mmHg baseline Recent myocardial infarction stroke Secondary hypertension Contraindications betablocker therapy discontinuation prior antihypertensive agent Pregnancy , nurse woman childbearing age use appropriate contraception</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Nebivolol</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Beta-Blockers</keyword>
</DOC>